Search

everythinglearnresearchcommunity

for

Search:↓

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Fibrodysplasia ossificans progressiva is a rare genetic disorder that causes extra bone growth and symptoms of premature aging.

Hair follicle stem cells help maintain skin health and could improve skin replacement therapies.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Deoxyshikonin helps wounds heal faster in diabetic mice.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Blocking neurosteroid production can lead to more seizures and faster epilepsy onset in rats.

Cattle skin has leptin which might control skin and hair growth.

Vitamin D might be involved in the development of alopecia areata and could help in its treatment.

Rosemary may help treat various skin conditions due to its antioxidant and anti-inflammatory properties.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

Special gels help heal diabetic foot sores and reduce the risk of amputation or death.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Genomic research can help improve the quality and production of natural fibers in animals.

Certain microRNAs are important for sheep hair follicle development and could help improve wool quality.

Fat tissue under the skin affects hair growth and aging; reducing its inflammation may help treat hair loss.

Proteomics combined with other technologies can lead to a better understanding of skin diseases.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Platelet lysate effectively promotes hair growth and improves hair thickness in people with androgenetic alopecia.

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

Laser treatment and synovial fluid can change hair follicle cells to resemble joint cells, with the changes being more significant when both treatments are used together.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Microneedles could be a better and easier way to regrow hair.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.